Medtronic Ablation Frontiers Cardiac Ablation System Delivers Treatment for the Most Common Heart Arrhythmia

Stocks resumed their tug of war when the worst August in nine years was quickly followed by the strongest start to September since 1998. Robust manufacturing data from Beijing to Baltimore ensured that in an ongoing battle between the market’s great twin impostors of fear and greed the former ceded center stage. Gordon Gekko who once infamously exalted the latter would have approved even if his ailing alter ego is wise enough to know better. “Lunch is for wimps” was another of the character’s catchphrases but he presumably never dined at Burger King (BKC) whose 14.65% surge continues the ...

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5941565 for the full story.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

These large-cap stocks look pretty cheap.

Weston, August 28th (Tradershuddle.com) – Stocks finished a volatile week, with a rally, on speculation the Fed will step in to aid the stalling economic recovery. Economic worries and dismal housing data outweighed increased M&A activity.

For the week, the blue chip index f. Read More --

Medtronic (NYSE:MDT) has received approval from Health Canada for ablation frontier cardiac ablation system, a radiofrequency ablation technology for the treatment of atrial fibrillation (AF). The device consists of the Genius multi-channel radiofrequency generator and the pulmonary vein ablation catheter (PVAC). As a condition of the approval, the company has to provide updates on the ...

BloggingStocks: Medical technology company Medtronic (MDT), whose colleagues include Boston Scientific (BSX) and Johnson & Johnson (JNJ), has not had a good year. The chart communicates a very bearish situation. But when a stock takes a significant dip, many ... Read more

Eddy Elfenbein, “Basic economics tells us that profits can only go so far without sales growth — sales growth has been dismal. “  (Crossing Wall Street) Bond yields are low, but what about real yields?  (Bespoke) A trade to play a pullback in bonds.  (Milk Trader) Despite some advances, muni bond pricing for individuals is still a minefield.  [...]

We reaffirm our Neutral recommendation on DexCom Inc (DXCM), a prominent player in the continuous glucose monitoring market. Second-quarter fiscal 2010 loss per share of 20 cents matched the Zacks Consensus Estimate while revenues soared 75% year-over-year riding on solid product sales. DexCom is a medical devices company focused on the design, development and commercialization of [...]

(DXCM) DexCom Analyst Reiterates Stock at Neutral

Two Veteran Wall Street Analysts discuss: (Vern:) SCG, ZMH, HRC; (Val:) CAH, MDT, OMI

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Companies featured in this segment: Medtronic Incorporated (NYSE:MDT), E.ON Climate & Renewables (Xetra:EONGn.DE), Poweo S.A. (EPA:ALPWO), Verbund (WBAG:VER), Essar Steel Limited (BSE:500627), General Motors (NYSE:GM), Severstal (MCX:CHMF), Power Grid Corporation of India (BSE:532898), PetroChina Company Limited (NYSE:PTR), China Petroleum & Chemical Corporation (NYSE:SNP), (NASDAQ:SIAL)

Schaeffer's Colleen S. King takes a look at activity on the Street ahead of the market open

Beth Gaston Moon takes a look at activity in the options pits today.